Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development

<p>SAN MATEO, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) &#8212; Bluejay Therapeutics, Inc. a private clinical stage biopharmaceutical company focused on viral and liver diseases, today announced the appointment of Christopher Holterhoff as Senior Vice President, Head of Business Development. Mr. Holterhoff will lead Bluejay’s business and corporate development function and will play a significant role [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/bluejay-therapeutics-expands-management-team-and-hired-christopher-holterhoff-as-senior-vice-president-head-of-business-development/">Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>